SCHEMBL30829344

SCHEMBL30829344

CN(C(=O)OCc1ccccc1)C1CN(C(=O)O)C1

nearest known ligand 0.54

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SIGMAR1 Q99720 1/20 0.54
CCR5 P51681 3/20 0.48
CHRM2 P08172 1/20 0.45
CHRM5 P08912 1/20 0.45
CHRM1 P11229 1/20 0.45
CHRM3 P20309 1/20 0.45
ALDH1A1 P00352 4/20 0.45
SMN1; SMN2 Q16637 2/20 0.44
NPC1 O15118 1/20 0.44
RAB9A P51151 1/20 0.44
CTSL P07711 1/20 0.43
CTSB P07858 1/20 0.43
CTSS P25774 1/20 0.43
CTSK P43235 1/20 0.43
HTR2C P28335 1/20 0.43
MAPT P10636 1/20 0.43
HPGD P15428 1/20 0.43
CYP2C19 P33261 1/20 0.42
MEN1 O00255 1/20 0.42
KMT2A Q03164 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13739933 0.90 SIGMAR1 (0.56) SIGMAR1CCR5CHRM2CHRM5CHRM1
SCHEMBL13738840 0.90 SIGMAR1 (0.56) SIGMAR1CCR5CHRM2CHRM5CHRM1
SCHEMBL3671431 0.90 SIGMAR1 (0.56) SIGMAR1CCR5CHRM2CHRM5CHRM1
SCHEMBL17700060 0.87 SIGMAR1 (0.57) SIGMAR1CCR5CHRM2CHRM5CHRM1
SCHEMBL785198 0.86 SIGMAR1 (0.58) SIGMAR1CCR5CHRM2CHRM5CHRM1
SCHEMBL17438170 0.86 SIGMAR1 (0.52) SIGMAR1CCR5CHRM2CHRM5CHRM1
SCHEMBL25257016 0.86 SIGMAR1 (0.61) SIGMAR1CCR5CHRM2CHRM5CHRM1
SCHEMBL25257018 0.86 SIGMAR1 (0.61) SIGMAR1CCR5CHRM2CHRM5CHRM1
SCHEMBL29593677 0.85 JAK2 (0.51) SIGMAR1CCR5SMN1; SMN2NPC1RAB9A
SCHEMBL31748093 0.84 SIGMAR1 (0.47) SIGMAR1CCR5CHRM2CHRM5CHRM1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2024034591-A1 HETEROCYCLIC COMPOUND FOR INHIBITING AND/OR INDUCING DEGRADATION OF KRAS PROTEIN アステラス製薬株式会社 2024-02-15 WO disclosed